Format

Send to

Choose Destination
J Exp Clin Cancer Res. 2018 Aug 13;37(1):189. doi: 10.1186/s13046-018-0855-7.

MKRN2 inhibits migration and invasion of non-small-cell lung cancer by negatively regulating the PI3K/Akt pathway.

Author information

1
Department of Pathology, First Affiliated Hospital College and of Basic Medical Sciences China Medical University, No. 155 Nanjing North Street, Heping District, Shenyang, 110001, Liaoning, China.
2
Jilin Zhongzheng Judicial Appraisal Institute, Changchun, China.
3
Department of Pathology, General Hospital of Liaohe Oil Field, Panjin, China.
4
Department of Pathology, First Affiliated Hospital College and of Basic Medical Sciences China Medical University, No. 155 Nanjing North Street, Heping District, Shenyang, 110001, Liaoning, China. xsqiu@cmu.edu.cn.

Abstract

BACKGROUND:

Makorin RING zinc finger-2 (MKRN2) belongs to the makorin RING zinc finger family and is a novel ubiquitin E3 ligase targeting the p65 subunit of NF-κB to negatively regulate inflammatory responses; however, the relationship between MKRN2 and tumorigenesis remains unclear. In this study, we clarified the role of MKRN2 in non-small cell lung cancer (NSCLC).

METHODS:

Tumor specimens collected from 261 NSCLC patients from 2013 to 2017 were retrieved from the Pathology Archive of the First Affiliated Hospital of China Medical University, and we performed assays to evaluate MKRN2 expression and to determine the impact of MKRN2 silencing and overexpression on NSCLC-cell migration and invasion.

RESULTS:

We demonstrated that MKRN2 expression was associated with lymph node metastasis, p-TNM stage, cancer-cell differentiation, and poor prognosis. By altering the expression of MKRN2 in selected cell lines, we found that MKRN2 inhibited cell migration and invasion through downregulation of the PI3K/Akt pathway.

CONCLUSIONS:

These results suggested that MKRN2 inhibited NSCLC progression by reducing the metastatic potential of cancer cells. Our findings provide critical insight into the association of MKRN2 expression with favorable clinicopathological characteristics in NSCLC patients and suggested that MKRN2 plays a role in inhibiting NSCLC development.

KEYWORDS:

Cell invasion; Cell migration; MKRN2; Non-small-cell lung cancer; PI3K/Akt pathway; Ubiquitination

PMID:
30103781
PMCID:
PMC6090690
DOI:
10.1186/s13046-018-0855-7
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center